CLINICAL DEVELOPMENT STRATEGY
When entering a new therapeutic area hinged on a well-reasoned clinical development strategy
and market assessment, a large biotech company relied on Health Advances to show the way. COMMERCIALIZATION STRATEGY
Facing multiple possible lead indications, we helped our client define a logical
development path to minimize risk and optimize value. DIAGNOSTICS INDUSTRY STRATEGY
When the senior management team of a Fortune 500 diagnostics company needed an
advisor to challenge their thinking and develop an acquisition strategy, they
sought out Health Advances.
FRANCHISE STRATEGY
From defining a vision to completing a major acquisition, Health Advances was there
to assist our client with every step in building a formidable CNS franchise.
PORTFOLIO PRIORITIZATION
Facing multiple possible lead indications, we helped our client define a logical
development path to minimize risk and optimize value. REIMBURSEMENT AND PRICING STRATEGY
Pricing considerations influence almost every decision. Prior to launching a novel
oncology drug for the first of four indications, our client required a clear strategy
to optimize the initial launch price.
DIAGNOSTIC ASSAY GLOBAL LAUNCH (PDF: 198KB)
Worldwide commercialization of an HIV diagnostic assay.
GLOBAL INSULIN STRATEGY (PDF: 35KB)
Developing a global insulin strategy for a major pharmaceutical company.
GLOBAL MANUFACTURING CAPACITY FORECAST (PDF: 35KB)
Determining worldwide manufacturing capacity requirements and the likely demand for outsourced manufacturing of therapeutic proteins.
NEW PRODUCT FORECAST IN DEVELOPING COUNTRIES (PDF: 23KB)
Forecasting the uptake of a novel infectious disease testing platform for rural regions in developing countries.
PROGRESS ASSESSMENT FOR A GLOBAL HEALTH ORGANIZATION (PDF: 44KB)
Independent evaluation of the impact of an international nonprofit organization and its plans for the future.
